Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GM-CSF”

484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 484 results

Testing effectiveness (Phase 2)UnknownNCT04106180
What this trial is testing

SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC

Who this might be right for
NSCLC Stage IV
Fudan University 63
Testing effectiveness (Phase 2)Ended earlyNCT00206661
What this trial is testing

Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 22
Testing effectiveness (Phase 2)Study completedNCT02474186
What this trial is testing

Phase II Study for Solid Metastatic Tumors

Who this might be right for
Breast CancerMetastatic Breast CancerSolid Tumor
NYU Langone Health 41
Testing effectiveness (Phase 2)Study completedNCT04569877
What this trial is testing

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) PneumoniaCOVID-19 Pneumonia
University of Giessen 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT02502786
What this trial is testing

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

Who this might be right for
Recurrent Osteosarcoma
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT03033303
What this trial is testing

The Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00309894
What this trial is testing

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 49
Early research (Phase 1)Study completedNCT02840708
What this trial is testing

SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study

Who this might be right for
Pulmonary Alveolar Proteinosis, Autoimmune
Niigata University Medical & Dental Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00616564
What this trial is testing

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Mt. Sinai Medical Center, Miami 36
Testing effectiveness (Phase 2)Study completedNCT00323557
What this trial is testing

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00847171
What this trial is testing

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT06961409
What this trial is testing

Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions

Who this might be right for
Periodontal DiseasesPeriodontitisGingivitis+1 more
Izmir Katip Celebi University 60
Testing effectiveness (Phase 2)UnknownNCT05115500
What this trial is testing

ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)

Who this might be right for
CarcinomaSolid Tumor
Second Affiliated Hospital of Soochow University 55
Early research (Phase 1)Study completedNCT00450307
What this trial is testing

Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00004197
What this trial is testing

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Not applicableEnded earlyNCT03164889
What this trial is testing

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Beijing 302 Hospital 80
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Post-approval studies (Phase 4)Study completedNCT01718210
What this trial is testing

Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure

Who this might be right for
Infertility
Centre for Endocrinology and Reproductive Medicine, Italy 100
Testing effectiveness (Phase 2)Study completedNCT00274287
What this trial is testing

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 15
Load More Results